US0311621009 - Common Stock
AMGEN INC
NASDAQ:AMGN (7/26/2024, 6:18:44 PM)
After market: 335 +0.15 (+0.04%)334.85
+0.55 (+0.16%)
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company is headquartered in Thousand Oaks, California and currently employs 26,700 full-time employees. The firm discovers, develops, manufactures and delivers various human therapeutics. The company focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. The company operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.
AMGEN INC
One Amgen Center Drive
Thousand Oaks CALIFORNIA 91320
P: 18054471000
CEO: Robert A. Bradway
Employees: 26700
Website: https://www.amgen.com/
The bull market in growth stocks is more than just chipmakers if investors will only widen their lens to see the opportunities available.
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Buying stocks while they're melting up isn't without its fair share of risk. That said, these high-flyers look pretty enticing.
Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.
Here you can normally see the latest stock twits on AMGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: